Current events
Jun 28-29, London, UK - RNAi, siRNA and miRNA
Dmitry Samarsky, Ph.D., VP of Technology Development session chair and presenting
July 18-23, Newport, RI – The Biology of Post Transcriptional Gene Regulation
Anastasia Khvorova, Ph.D., Chief Scientific Officer, presenting “Applications of rxRNA compounds in molecular diagnostics and therapeutics”
Sep 14-15, Dublin, Ireland - RNAi and miRNA Europe
Anastasia Khvorova, Ph.D., Chief Scientific Officer, presenting "sd-rxRNA - Novel Class of Self-Delivering RNAi Compounds: Robust in vitro and in vivo Efficacy with Broad Clinical Potential"
Past Events
May 30-Jun 1, San Feliu de Guixols, Spain- Antiviral Applications of RNA Interference
Dmitry Samarsky, Ph.D., VP of Technology Development presenting
May 5-7, Boston, MA - RNAi World Congress
- Anastasia Khvorova, Ph.D., Chief Scientific Officer delivering keynote
- Dmitry Samarsky, Ph.D., VP of Technology Development presenting “Combination of Oligo Configuration and Chemical Modification Provides Drug-Like Properties to RNAi Molecules”
May 2-6, Ft. Lauderdale, FL – Association for Research in Vision and Ophthalmology (ARVO)
Lyn Libertine, Director of Pharmacology presenting a poster entitled “Novel Self-delivering RNAi Compounds (sd-rxRNA™) Demonstrate Robust Ocular Cell Uptake in vitro and in vivo”
Apr 26-28, Boston, MA - Oligonucleotide Therapeutics Discovery
- Dmitry Samarsky, Ph.D., VP of Technology Development presenting “Combination of Oligo Configuration and Chemical Modification Provides Drug-Like Properties to RNAi Molecules”
- Joanne Kamens, Ph.D., Sr. Director, Research Alliances presenting “Design of Oligonucleotide Compound Screens: Using Early Design Parameters to Increase Success”
Apr 25-28, Boston, MA – TIDES
Pamela Pavco, Ph.D., VP of Pharmaceutical Development presenting “Optimization of RNAi for Therapeutic Development”
Apr 17-21, Washington, DC - AACR Annual Meeting
Anastasia Khvorova, Ph.D., Chief Scientific Officer presenting “RNAi: New Promise in Cancer Therapy” in the Meet-the-Expert Session
Apr 7-10, Cold Spring Harbor, NY – RNA and Oligonucleotide Therapeutics
Pamela Pavco, Ph.D., VP of Pharmaceutical Development presenting “Advances in the Therapeutic Use of RNA Interference (RNAi)”
Mar 30-31, Boston, MA – Massachusetts Biotechnology Council Annual Meeting
Anastasia Khvorova, Ph.D., Chief Scientific Officer, RNAi Therapeutics panel participant
Mar 25-27, Montpelier, France - SCAR Club
Pamela Pavco, Ph.D., VP of Pharmaceutical Development presenting “Evaluation of RNA interference (RNAi) in skin”
Mar 23-24, Bethesda, MA - DIA Oligonucleotide Therapeutics
Anastasia Khvorova, Ph.D., Chief Scientific Officer presenting “sd-rxRNA - Novel Class of Self-Delivering RNAi Compounds: Robust in vitro and in vivo Efficacy with Broad Clinical Potential”
Mar 17-18, Oxford, UK – RNAi2010
Dmitry Samarsky, Ph.D., VP of Technology Development session chair and presenting
Feb 22-25 – Asia TIDES
Pamela Pavco, Ph.D., VP of Pharmaceutical Development presenting
Feb 3-5 - RNA Interference: From Tools to Therapies
Joanne Kamens, Ph.D., Senior Director of Research Collaboration Management, presenting
Jan 26-27 – Drug Delivery Formulation
Dmitry Samarsky, Ph.D., VP of Technology Development presenting
Jan 14-19 – Keystone, RNAi Silencing: Mechanism, Biology and Application
RXi’s leading RNAi scientific team is presenting 4 posters
2009
Dec 02-03 – Informa Euro TIDES
Dmitry Samarsky, Ph.D., VP of Technology Development presenter and session chair
Nov 03-04 – CHI’s Discovery on Target for Therapeutics
Dmitry Samarsky, Ph.D., VP of Technology Development presenter and session chair
Sep 29-30 – PCI Pharma – Life Science Symposium
RXi’s Senior Director of Discovery, Joanne Kamens, Ph.D. presenting
Sept 23-25 - Institute for International Research - Formulation & Delivery of Macromolecules
RXi’s VP of Technology Development, Dmitry Samarsky, Ph.D. presenting
Sept 17-18 – Select Biosciences – RNAi Europe
RXi’s VP of Technology Development, Dmitry Samarsky, Ph.D. presenting
Sep 15-16 – PCI Pharma – Life Science Symposium
RXi’s President & CEO, Tod Woolf, Ph.D. delivering a keynote address
Aug 3-4 – IBC – Drug Discovery & Development of Innovative Therapeutics 2009
RXi’s President & CEO, Tod Woolf, Ph.D. participating in a CEO panel discussion
RXi’s VP of Technology Development, Dmitry Samarsky, Ph.D. presenting
June 21-25 – DIA – Drug Information Association 45th Annual Meeting
Dmitry Samarsky, Ph.D., VP of Technology Development presenter and session chair
June 8-10 – CHI – RNAi-Based Therapeutics
Presentation by Ramani Varanasi, MS, MBA, VP of Business Development
June 1-3 – IBC – Drug Discovery and Development, Japan
Dmitry Samarsky, Ph.D., VP of Technology Development presenter and session chair
May 21-23 – Academy of Pharma Science and Technology Meeting
Presentation by Dmitry Samarsky, Ph.D., VP of Technology Development
May 18-21 – BIO International Convention
Tod Woolf, Ph.D., President & CEO, chairs a session on the challenges and advances
in successful delivery of nucleic acid based drugs
May 18-20 – IMBA – Microsymposium on Small RNAs
Presentation by Dmitry Samarsky, Ph.D., VP of Technology Development
May 17-20 – TIDES – IBC’s Applications of Nucleic Acids Technologies in Molecular Diagnostics
Presentation by RXi Chief Scientific Officer, Anastasia Khvorova, Ph.D.
May 12-13 – Select Biosciences - DxRx Summit
Presenation by RXi VP of Technology Development, Dr. Dmitry Samarsky
May 8-12 - Immunology 2009—American Association of Immunologists (AAI) 96th Annual Meeting
Poster presentation by RXi Senior Director of Discovery, Dr. Joanne Kamens
Apr 25-30 – Keystone Symposia – The Biology of RNA Silencing
Keynote address by RXi founder/advisor Dr. Craig Mello
Section chaired by RXi Chief Scientific Officer, Dr. Anastasia Khvorova
Poster presentation by RXi Senior Director of Discovery, Dr. Joanne Kamens
Presentation by RXi scientific advisor Dr. Victor Ambros
Presentation by RXi founder/advisor Dr. Greg Hannon
Presentation by RXi founder/advisor Dr. Tariq Rana
Apr 18-22 - ASPET-American Society For Pharmacology and Experimental Therapeutics
Presenation by RXi VP of Pharmaceutical Development, Dr. Pamela Pavco
Apr 01-02 – Gene Expression Systems - RNAi & miRNA, Boston and Oligo & Peptide Therapeutics
Dr. Tod Woolf industry keynote speaker and Dr. Dmitry Samarsky session chair & presenter
Mar 18-19 – LPM/Oxford University RNAi2009
Dr. Dmitry Samarsky, session chair, presenter and scientific advisor
Feb 24 - New York Academy of Sciences
Dr. Tod Wolf presenting
Feb 23-25 – IBC Asia TIDES
Dr. Dmitry Samarsky chairing and presenting at the session "Worldwide Advances in RNAi"
Jan 22-23 – CBI Executing on the Promise of RNAi
Dr. Dmitry Samarsky presenting
Jan 21-23 – IIR 13th Annual Drug Delivery Partnerships
Dr. Joanne Kamens presenting
2008
Dec 2-3 – Informa’s EuroTides
Dr. Pamela Pavco presenting
Oct 27-29 – Informa’s Drug Delivery Partnershp
Dr. Dmitry Samarsky workshop coordinator
Oct 22-28 – CHI’s Discovery on Target
Dr. Tod Woolf presenter & Dr. Dmitry Samarsky, program chair
Oct 15-18 – OTS Symposium
Dr. Joanne Kamens presenter
Sept 22-24 – DIA Oligonucleotide-Based Therapeutics
Dr. Dmitry Samarsky, program chairman, session chairman, panel leader
Sept 17-18 - Select Biosciences RNAi Europe
Dr. Dmitry Samarsky presenting
July 09-11 – IBC microRNA and RNAi Industry Summit
Dr. Dmitry Samarsky, seminar learder and Dr. Pamela Pavco speaking
